Multiple sclerosis-quenching the flames of inflammation
- PMID: 22047970
- DOI: 10.1016/S0140-6736(11)61133-1
Multiple sclerosis-quenching the flames of inflammation
Comment on
-
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.Lancet. 2011 Nov 19;378(9805):1779-87. doi: 10.1016/S0140-6736(11)61649-8. Epub 2011 Oct 31. Lancet. 2011. PMID: 22047971 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
